Phase II study of neoadjuvant chemotherapy with CPT-11 and S-1 for locally advanced colorectal cancer with lymph node metastases.

ABSTRACT: Interventions: S-1 80mg/m2/day for 14 days plus CPT-11 100mg/m2 on day 1 and 15 every 28 days is administered for 2 course. After treatment, response rate is evaluated. Surgical operation is performed. Primary outcome(s): Response rate Study Design: Single arm Non-randomized

DISEASE(S): Locally Advanced Colorectal Cancer With Lymph Node Metastases

PROVIDER: 2617187 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR